Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies
- PMID: 28753039
- PMCID: PMC5649983
- DOI: 10.1164/rccm.201612-2431OC
Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies
Abstract
Rationale: The impact of a broad range of occupational exposures on subclinical interstitial lung disease (ILD) has not been studied.
Objectives: To determine whether occupational exposures to vapors, gas, dust, and fumes (VGDF) are associated with high-attenuation areas (HAA) and interstitial lung abnormalities (ILA), which are quantitative and qualitative computed tomography (CT)-based measurements of subclinical ILD, respectively.
Methods: We performed analyses of participants enrolled in MESA (Multi-Ethnic Study of Atherosclerosis), a population-based cohort aged 45-84 years at recruitment. HAA was measured at baseline and on serial cardiac CT scans in 5,702 participants. ILA was ascertained in a subset of 2,312 participants who underwent full-lung CT scanning at 10-year follow-up. Occupational exposures were assessed by self-reported VGDF exposure and by job-exposure matrix (JEM). Linear mixed models and logistic regression were used to determine whether occupational exposures were associated with log-transformed HAA and ILA. Models were adjusted for age, sex, race/ethnicity, education, employment status, tobacco use, and scanner technology.
Measurements and main results: Each JEM score increment in VGDF exposure was associated with 2.64% greater HAA (95% confidence interval [CI], 1.23-4.19%). Self-reported vapors/gas exposure was associated with an increased odds of ILA among those currently employed (1.76-fold; 95% CI, 1.09-2.84) and those less than 65 years old (1.97-fold; 95% CI, 1.16-3.35). There was no consistent evidence that occupational exposures were associated with progression of HAA over the follow-up period.
Conclusions: JEM-assigned and self-reported exposures to VGDF were associated with measurements of subclinical ILD in community-dwelling adults.
Keywords: community-based study; epidemiology; interstitial lung disease; occupational exposures; subclinical.
Figures

Comment in
-
Recognizing Workplace Factors Contributing to Interstitial Lung Disease.Am J Respir Crit Care Med. 2017 Oct 15;196(8):949-951. doi: 10.1164/rccm.201704-0766ED. Am J Respir Crit Care Med. 2017. PMID: 29028374 No abstract available.
Similar articles
-
Occupational risk factors for COPD phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.COPD. 2014 Aug;11(4):368-80. doi: 10.3109/15412555.2013.813448. Epub 2014 Feb 25. COPD. 2014. PMID: 24568208 Free PMC article.
-
Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis.COPD. 2015 Apr;12(2):182-9. doi: 10.3109/15412555.2014.922173. Epub 2014 Jul 1. COPD. 2015. PMID: 24983136 Free PMC article.
-
Occupational Exposure to Vapor-Gas, Dust, and Fumes in a Cohort of Rural Adults in Iowa Compared with a Cohort of Urban Adults.MMWR Surveill Summ. 2017 Nov 3;66(21):1-5. doi: 10.15585/mmwr.ss6621a1. MMWR Surveill Summ. 2017. PMID: 29095802 Free PMC article.
-
[Occupational interstitial lung diseases].Radiologie (Heidelb). 2024 Aug;64(8):636-642. doi: 10.1007/s00117-024-01342-9. Epub 2024 Jul 16. Radiologie (Heidelb). 2024. PMID: 39012478 Free PMC article. Review. German.
-
The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Ann Am Thorac Soc. 2024 Mar;21(3):486-498. doi: 10.1513/AnnalsATS.202305-402OC. Ann Am Thorac Soc. 2024. PMID: 38096107 Free PMC article.
Cited by
-
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives.Eur Respir Rev. 2022 Apr 13;31(164):210206. doi: 10.1183/16000617.0206-2021. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35418487 Free PMC article. Review.
-
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2024 Sep;21(9):1251-1260. doi: 10.1513/AnnalsATS.202308-741OC. Ann Am Thorac Soc. 2024. PMID: 38568439
-
Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).J Nutr. 2018 Jul 1;148(7):1126-1134. doi: 10.1093/jn/nxy066. J Nutr. 2018. PMID: 29931068 Free PMC article.
-
Current Landscape and Future Directions of Patient Education in Adults with Interstitial Lung Disease.ATS Sch. 2023 Oct 18;5(1):184-205. doi: 10.34197/ats-scholar.2023-0069RE. eCollection 2024 Mar. ATS Sch. 2023. PMID: 38633514 Free PMC article. Review.
-
Interstitial Lung Abnormalities: Unraveling the Journey from Incidental Discovery to Clinical Significance.Diagnostics (Basel). 2025 Feb 19;15(4):509. doi: 10.3390/diagnostics15040509. Diagnostics (Basel). 2025. PMID: 40002659 Free PMC article. Review.
References
-
- Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med. 2014;2:566–572. - PubMed
-
- American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–304. - PubMed
-
- Taskar V, Coultas D. Exposures and idiopathic lung disease. Semin Respir Crit Care Med. 2008;29:670–679. - PubMed
-
- Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA Collaborating Centers. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol. 2000;152:307–315. - PubMed
-
- Hubbard R. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J Suppl. 2001;32:119s–121s. - PubMed
MeSH terms
Substances
Grants and funding
- N01 HC095161/HL/NHLBI NIH HHS/United States
- T32 HL105323/HL/NHLBI NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- T32 HL007287/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- T42 OH008433/OH/NIOSH CDC HHS/United States
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- HHSN263201500003I/NH/NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- P30 ES005605/ES/NIEHS NIH HHS/United States
- R01 HL112986/HL/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- RC1 HL100543/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- K24 HL131937/HL/NHLBI NIH HHS/United States
- R01 HL103676/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- K24 HL103844/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials